Personnel Information

写真a

MURAMATSU Tomoki


Job title

Assistant Professor

Birth date

1983

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Doctor's Course, 2013.03, Completed

Campus Career 【 display / non-display

  • 2014.04
    -
    2017.10
    Tokyo Medical and Dental University, Medical Research Institute, Medical Genomics, Molecular Cytogenetics, Assistant Professor
  • 2014.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Molecular Cytogenetics, Assistant Professor
  • 2017.11
    -
    Now
    Tokyo Medical and Dental University, Medical Research Institute, Assistant Professor

External Career 【 display / non-display

  • 2016.10
    -
    2017.09
    The Scripps Research Institute, Department of Molecular Medicine, Research Associate

Research Areas 【 display / non-display

  • Tumor biology

 

Published Papers & Misc 【 display / non-display

  1. Liu C, Gen Y, Tanimoto K, Muramatsu T, Inoue J, Inazawa J. Concurrent targeting of MAP3K3 and BRD4 by <i>miR-3140-3p</i> overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular therapy. Nucleic acids. 2021.09; 25 83-92. ( PubMed, DOI )

  2. Gen Y, Muramatsu T, Inoue J, Inazawa J. miR-766-5p targets super-enhancers by downregulating CBP and BRD4. Cancer research. 2021.08; ( PubMed, DOI )

  3. Nishino K, Yoshimatsu Y, Muramatsu T, Sekimoto Y, Mitani K, Kobayashi E, Okamoto S, Ebana H, Okada Y, Kurihara M, Suzuki K, Inazawa J, Takahashi K, Watabe T, Seyama K. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis. Scientific reports. 2021.04; 11 (1): 8406. ( PubMed, DOI )

  4. Xu B, Muramatsu T, Inazawa J. Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell Growth. Molecular cancer research : MCR. 2021.04; 19 (4): 585-597. ( PubMed, DOI )

  5. Muramatsu Tomoki, Xu Bo, Inazawa Johji. Pitavastatin inhibits the tumor growth through the suppression of AKT and ERK signals in oral and esophageal cancer CANCER SCIENCE. 2021.02; 112 285.

  6. Deryugina E, Carré A, Ardi V, Muramatsu T, Schmidt J, Pham C, Quigley JP. Neutrophil Elastase Facilitates Tumor Cell Intravasation and Early Metastatic Events. iScience. 2020.12; 23 (12): 101799. ( PubMed, DOI )

  7. 村松 智輝, 徐 博, 稲澤 譲治. 口腔・食道がんにおいてピタバスタチンはAKT、ERKのシグナルを抑制し、細胞増殖を阻害する 日本癌学会総会記事. 2020.10; 79回 OE5-2. ( ichushi )

  8. Takagawa Y, Gen Y, Muramatsu T, Tanimoto K, Inoue J, Harada H, Inazawa J. miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway. Molecular therapy : the journal of the American Society of Gene Therapy. 2020.06; 28 (6): 1494-1505. ( PubMed, DOI )

  9. Tanimoto K, Muramatsu T, Inazawa J. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas. Cancer medicine. 2019.12; 8 (17): 7372-7384. ( PubMed, DOI )

  10. 村松 智輝, 佐藤 拓, 田邉 稔, 稲澤 譲治. 循環腫瘍細胞亜株(Panc-1-CTC)の発現解析から見出したTGFBIの機能解析(Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line) 日本癌学会総会記事. 2019.09; 78回 P-1058. ( ichushi )

  11. 吉松 康裕, 赤津 裕一, 高橋 直也, 紀室 志織, 村松 智輝, 桂 彰宏, 間石 奈湖, 鈴木 洋, 稲澤 譲治, 樋田 京子, 宮園 浩平, 渡部 徹郎. 線維芽細胞増殖因子(FGF2)は腫瘍血管内皮細胞においてTGF-βによって誘導される内皮-筋線維芽移行を制御する(Fibroblast growth factor 2 regulates TGF-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells) 日本癌学会総会記事. 2019.09; 78回 P-2280. ( ichushi )

  12. 内藤 諒, 村松 智輝, 谷本 幸介, 稲澤 譲治. 統合的mRNA, miRNA発現情報を基盤とした独自のマイクロRNA標的遺伝子予測データベースの構築(Construction of an in-house microRNA-target prediction database based on an integrative mRNA-microRNA expression data) 日本癌学会総会記事. 2019.09; 78回 E-1063. ( ichushi )

  13. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 機能的miRNAライブラリースクリーニングによる、BRD4を標的とする新規癌抑制型miRNAの同定(Function-based microRNA library screening identified novel tumor suppressive microRNAs targeting BRD4) 日本癌学会総会記事. 2019.09; 78回 P-1238. ( ichushi )

  14. 玄 泰行, 村松 智輝, 井上 純, 稲澤 譲治. 新規癌抑制型miRNAによるMYC標的核酸抗癌治療の可能性(Oligonucleotide therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway) 日本癌学会総会記事. 2019.09; 78回 P-3226. ( ichushi )

  15. 徐 博, 村松 智輝, 稲澤 譲治. 扁平上皮がん細胞においてピタバスタチンはAKT、ERKの抑制を介して細胞増殖を阻害する(Pitavastatin inhibits the cell growth through the downregulation of AKT and ERK in squamous cell carcinoma) 日本癌学会総会記事. 2019.09; 78回 P-3166. ( ichushi )

  16. Akatsu Y, Takahashi N, Yoshimatsu Y, Kimuro S, Muramatsu T, Katsura A, Maishi N, Suzuki HI, Inazawa J, Hida K, Miyazono K, Watabe T. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1. Molecular oncology. 2019.08; 13 (8): 1706-1724. ( PubMed, DOI )

  17. Muramatsu Tomoki, Sato Taku, Tanabe Minoru, Inazawa Johji. Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  18. Takagawa Yuki, Gen Yasuyuki, Muramatsu Tomoki, Harada Hiroyuki, Inazawa Johji. Exploring novel tumor suppressive microRNAs in OSCC CANCER SCIENCE. 2018.12; 109 1083.

  19. Sato Taku, Muramatsu Tomoki, Tanabe Minoru, Inazawa Johji. 膵癌細胞株由来の循環腫瘍細胞系で誘導したトランスフォーミング成長因子βの同定と特性評価(Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line) Cancer Science. 2018.11; 109 (11): 3623-3633. ( ichushi )

  20. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 口腔扁平上皮癌における新規のがん抑制型マイクロRNAの探索(Exploring novel tumor suppressive microRNAs in OSCC) 日本癌学会総会記事. 2018.09; 77回 1922. ( ichushi )

  21. Sato T, Muramatsu T, Tanabe M, Inazawa J. Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line. Cancer science. 2018.08; ( PubMed, DOI )

  22. Muramatsu Tomoki, Tonouchi Erina, Gen Yasuyuki, Hiramoto Hidekazu, Tanimoto Kousuke, Inoue Jun, Inazawa Johji. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein CANCER RESEARCH. 2018.07; 78 (13): ( DOI )

  23. 高橋 和樹, 井上 ポディマ カタジナ アンナ, 高尾 千紘, 吉松 康裕, 村松 智輝, 稲澤 譲治, 渡部 徹郎. 口腔扁平上皮がん細胞HOC313-LMの運動能と腫瘍形成能の制御におけるトランスフォーミング増殖因子βシグナルの役割(Regulatory Role of Transforming Growth Factor-β Signals in the Migration and Tumor Formation of HOC313-LM cells, an Oral Squamous Cell Carcinoma) 口腔病学会雑誌. 2018.07; 85 (2): 52-61. ( ichushi )

  24. Deryugina EI, Zajac E, Zilberberg L, Muramatsu T, Joshi G, Dabovic B, Rifkin D, Quigley JP. LTBP3 promotes early metastatic events during cancer cell dissemination. Oncogene. 2018.04; 37 (14): 1815-1829. ( PubMed, DOI )

  25. Tonouchi E, Gen Y, Muramatsu T, Hiramoto H, Tanimoto K, Inoue J, Inazawa J. Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific reports. 2018.04; 8 (1): 6769. ( PubMed, DOI )

  26. Tonouchi E, Gen Y, Muramatsu T, Hiramoto H, Tanimoto K, Inoue J, Inazawa J. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific reports. 2018.03; 8 (1): 4482. ( PubMed, DOI )

  27. Tonouchi Erina, Muramatsu Tomoki, Gen Yasuyuki, Hiramoto Hidekazu, Inazawa Johji. Function-based microRNA library screening identified a novel tumor suppressive miRNA regulating BRD4, a BET family gene CANCER SCIENCE. 2018.01; 109 597.

  28. Hiramoto Hidekazu, Muramatsu Tomoki, Ichikawa Daisuke, Otsuji Eigo, Inazawa Johji. miR-509-5p and miR-1243 inhibit epithelial-mesenchymal transition in pancreatic cancer. CANCER SCIENCE. 2018.01; 109 601.

  29. Hiramoto Hidekazu, Muramatsu Tomoki, Ichikawa Daisuke, Tanimoto Kousuke, Komatsu Syuhei, Yasukawa Satoru, Otsuji Eigo, Inazawa Johji. Exploring Epithelial-Mesenchymal Transition: Suppressive miRNAs Using Combination of Cell-Based Reporter System and miRNA Library JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2017.10; 225 (4): E121-E122.

  30. 平本 秀一, 村松 智輝, 市川 大輔, 大辻 英吾, 稲澤 譲治. miR-509-5pとmiR-1243は膵癌においてEMTを抑制する 日本癌学会総会記事. 2017.09; 76回 P-2061. ( ichushi )

  31. 外内 えり奈, 村松 智輝, 玄 泰行, 平本 秀一, 稲澤 譲治. 機能的miRNAライブラリースクリーニングを用いた、BET family遺伝子を制御するがん抑制型miRNAの同定 日本癌学会総会記事. 2017.09; 76回 P-2055. ( ichushi )

  32. Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget. 2017.06; 8 (23): 37740-37750. ( PubMed, DOI )

  33. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, Inazawa J. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Scientific reports. 2017.06; 7 (1): 4002. ( PubMed, DOI )

  34. Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Scientific reports. 2016.12; 6 38750. ( PubMed, DOI )

  35. Muramatsu T., Kozaki K-I, Imoto S., Yamaguchi R., Tsuda H., Kawano T., Fujiwara N., Morishita M., Miyano S., Inazawa J.. The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma ONCOGENE. 2016.10; 35 (40): 5304-5316. ( DOI )

  36. 外内 えり奈, 村松 智輝, 平本 秀一, 稲澤 譲治. MicroRNAを介したBET familyとmTOR経路阻害によるがん細胞増殖抑制機構 日本癌学会総会記事. 2016.10; 75回 J-3083. ( ichushi )

  37. 平本 秀一, 村松 智輝, 市川 大輔, 大辻 英吾, 稲澤 譲治. 細胞ベースのレポーターシステムとmiRNAライブラリーを用いてのEMT抑制miRNAの探索 日本癌学会総会記事. 2016.10; 75回 J-3087. ( ichushi )

  38. 村松 智輝, 小崎 健一, 稲澤 譲治. がん転移におけるマイクロRNAとWNT経路の役割 日本癌学会総会記事. 2016.10; 75回 IS2-2. ( ichushi )

  39. Morishita M, Muramatsu T, Suto Y, Hirai M, Konishi T, Hayashi S, Shigemizu D, Tsunoda T, Moriyama K, Inazawa J. Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system. Oncotarget. 2016.03; 7 (9): 10182-92. ( PubMed, DOI )

  40. Okada Y, Muramatsu T, Suita N, Kanai M, Kawakami E, Iotchkova V, Soranzo N, Inazawa J, Tanaka T. Significant impact of miRNA-target gene networks on genetics of human complex traits. Scientific reports. 2016.03; 6 22223. ( PubMed, DOI )

  41. Morishita Maki, Muramatsu Tomoki, Suto Yumiko, Hirai Momoki, Konishi Teruaki, Hayashi Shin, Shigemizu Daichi, Tsunoda Tatsuhiko, Moriyama Keiji, Inazawa Johji. Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system ONCOTARGET. 2016.03; 7 (9): 10182-10192.

  42. Yanaka Y, Muramatsu T, Uetake H, Kozaki K, Inazawa J. miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis. 2015.11; 36 (11): 1363-71. ( PubMed, DOI )

  43. 村松 智輝, 谷中 淑光, 原園 陽介, 小崎 健一, 稲澤 譲治. miR-655とmiR-544aはEMTレポーターシステムにより同定されたEMT制御miRNAである 日本癌学会総会記事. 2015.10; 74回 J-1276. ( ichushi )

  44. Sakha Sujata, 村松 智輝, 稲澤 譲治. 高転移性がん細胞から分泌されるエクソソームは細胞増殖、移動・浸潤能を亢進させる 日本癌学会総会記事. 2015.10; 74回 E-1197. ( ichushi )

  45. 佐藤 拓, 村松 智輝, 田邉 稔, 稲澤 譲治. 膵癌循環腫瘍細胞の機能解析 日本癌学会総会記事. 2015.10; 74回 J-1259. ( ichushi )

  46. 平本 秀一, 村松 智輝, 市川 大輔, 大辻 英吾, 稲澤 譲治. 膵癌におけるcell-based reporter systemを用いたEMT関連miRNAの探索 日本癌学会総会記事. 2015.10; 74回 J-1357. ( ichushi )

  47. 森下 真紀, 村松 智輝, 林 深, 平井 百樹, 数藤 由美子, 小西 輝昭, 森山 啓司, 稲澤 譲治. 癌細胞ゲノムにおける局所マイクロビーム照射装置SPICEによる放射照射後のクロモスリプシス様変化 日本癌学会総会記事. 2015.10; 74回 P-1165. ( ichushi )

  48. Morishita Maki, Muramatsu Tomoki, Hayashi Shin, Hirai Momoki, Suto Yumiko, Konishi Teruaki, Moriyama Keiji, Inazawa Johji. Exploration of mechanisms for chromothripsis by irradiation CANCER RESEARCH. 2015.08; 75 ( DOI )

  49. Muramatsu Tomoki, Kozaki Ken-ichi, Imoto Seiya, Yamaguchi Rui, Tsuda Hitoshi, Kawano Tatsuyuki, Morishita Maki, Miyano Satoru, Inazawa Johji. The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma CANCER RESEARCH. 2015.08; 75 ( DOI )

  50. Muramatsu Tomoki, Kozaki Ken-ichi, Imoto Seiya, Yamaguchi Rui, Tsuda Hitoshi, Kawano Tatsuyuki, Miyano Satoru, Inazawa Johji. Exploring target gene(s) within chromosome 19-amplification detected in a subclone from metastatic tumors in mouse transplantable OSCC CANCER RESEARCH. 2014.10; 74 (19): ( DOI )

  51. 森下 真紀, 村松 智輝, 林 深, 平井 百樹, 数藤 由美子, 森山 啓司, 稲澤 譲治. 新規発癌機構であるchromothripsis生成機序の解明(Exploration of mechanisms for chromothripsis: a novel mechanism of carcinogenesis) 日本癌学会総会記事. 2014.09; 73回 J-3006. ( ichushi )

  52. 村松 智輝, 小崎 健一, 井元 清哉, 山口 類, 津田 均, 森下 真紀, 河野 辰幸, 宮野 悟, 稲澤 譲治. 高転移腫瘍における統合的解析から同定された新規治療標的経路ハイプシンカスケードの解析(The hypusine cascade as a novel therapeutic target emerged through integrated omics in highly metastatic tumors) 日本癌学会総会記事. 2014.09; 73回 J-3085. ( ichushi )

  53. 村松 智輝, 小崎 健一, 井元 清哉, 山口 類, 宮野 悟, 稲澤 譲治. 口腔がん細胞株に認められた19番染色体の増幅領域に座位する遺伝子は、Rhoシグナル経路を介して転移に寄与している可能性がある(Chromosome 19 amplicon in oral cancer cell line have the potential to promote metastasis via Rho signaling pathway) 日本癌学会総会記事. 2013.10; 72回 311. ( ichushi )

  54. Muramatsu Tomoki, Kozaki Ken-ichi, Imoto Seiya, Yamaguchi Rui, Miyano Satoru, Inazawa Johji. Exploring the role of up-regulated genes in highly metastatic oral cancer subline using spontaneous metastatic mouse model CANCER RESEARCH. 2013.04; 73 (8): ( DOI )

  55. Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer. Carcinogenesis. 2013.03; 34 (3): 560-9. ( PubMed, DOI )

  56. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, Inazawa J, Kozaki K. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PloS one. 2013.03;

  57. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, Inazawa J, Kozaki K. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PloS one. 2013; 8 (5): e62757. ( PubMed, DOI )

  58. Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, Inazawa J, Golden A, Carey DJ, Farooq A, Tromp G, Sudol M. Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene. 2012.11; 509 (2): 215-22. ( PubMed, DOI )

  59. Ono H., Imoto I., Kozaki K., Tsuda H., Matsui T., Kurasawa Y., Muramatsu T., Sugihara K., Inazawa J.. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation ONCOGENE. 2012.11; 31 (47): 4923-4934. ( DOI )

  60. 原園 陽介, 小崎 健一, 村松 智輝, 河野 辰幸, 原田 清, 稲澤 譲治. E-cadherinの発現変化を指標とした機能的スクリーニングによるMET誘導性microRNAの探索(Exploration of MET-inducing microRNAs using function-based screening with expression analysis of E-cadherin) 日本癌学会総会記事. 2012.08; 71回 87-88. ( ichushi )

  61. 村松 智輝, 小崎 健一, 井元 清哉, 山口 類, 宮野 悟, 稲澤 譲治. ヒト口腔癌細胞株を用いた癌転移分子メカニズムの解析(Analysis of molecular mechanisms of spontaneous metastasis in mouse model using human oral cancer cell line) 日本癌学会総会記事. 2012.08; 71回 423. ( ichushi )

  62. Matsumura S, Imoto I, Kozaki K, Matsui T, Muramatsu T, Furuta M, Tanaka S, Sakamoto M, Arii S, Inazawa J. Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012.07; 18 (13): 3541-51. ( PubMed, DOI )

  63. Harazono Yosuke, Kozaki Ken-ichi, Muramatsu Tomoki, Kurasawa Yasuhiro, Uzawa Narikazu, Amagasa Teruo, Inazawa Johji. Exploration of EMT-related microRNAs using function-based screening with expression analysis of E-cadherin in Panc1 line CANCER RESEARCH. 2012.04; 72 ( DOI )

  64. Kurasawa Y., Kozaki K., Pimkhaokham A., Muramatsu T., Ono H., Ishihara T., Uzawa N., Imoto I., Amagasa T., Inazawa J.. Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells ONCOGENE. 2012.04; 31 (15): 1963-1974. ( DOI )

  65. Kozaki Ken-ichi, Kurasawa Yasuhiro, Muramatsu Tomoki, Ono Hiroaki, Ishihara Takaya, Uzawa Narikazu, Pimkhaokham Atiphan, Imoto Issei, Amagasa Teruo, Inazawa Johji. Phenotypic stabilization of mesenchymal-like cancer cells through mesenchymal-specific DNA hypermethylation CANCER RESEARCH. 2012.04; 72 ( DOI )

  66. 原園 陽介, 小崎 健一, 村松 智輝, 倉沢 泰浩, 天笠 光雄, 稲澤 譲治. 膵癌細胞株におけるE-cadherinの発現変化を指標とした機能的スクリーニングによるEMT関連microRNAの探索(Exploration of EMT-related microRNAs using function-based screening with expression analysis of E-cadherin in Panel line) 日本癌学会総会記事. 2011.09; 70回 77. ( ichushi )

  67. 村松 智輝, 小崎 健一, 稲澤 譲治. 膵臓がん細胞株Panc1を用いた自発的転移モデルの構築と検証(Establishment and characterization of a spontaneous metastatic model using a human pancreatic cancer cell line, Panc1) 日本癌学会総会記事. 2011.09; 70回 126. ( ichushi )

  68. Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M, Shimada Y, Tsuda H, Kawano T, Inazawa J. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis. 2011.03; 32 (3): 389-98. ( PubMed, DOI )

  69. 村松 智輝, 井本 逸勢, 松井 毅, 小崎 健一, 嶋田 裕, 津田 均, 稲澤 譲治. 食道扁平上皮がんにおけるYes-associated protein(YAP)のがん遺伝子としての可能性(Yes-associated protein (YAP) as a potential oncogene for esophageal squamous-cell carcinoma (ESCC)) 日本癌学会総会記事. 2010.08; 69回 219. ( ichushi )

  70. 宮脇 豊, 井本 逸勢, 春木 茂男, 村松 智輝, 松井 毅, 小崎 健一, 河内 洋, 嶋田 裕, 河野 辰幸, 稲澤 譲治. 食道扁平上皮癌において高頻度に発現抑制される癌関連抑制遺伝子PCDH-X、Yの同定(Members of protocadherin superfamily is frequently silenced and work as potential tumor suppressors in esophageal) 日本癌学会総会記事. 2010.08; 69回 316. ( ichushi )

  71. 井本 逸勢, 春木 茂男, 小崎 健一, 松井 毅, 河内 洋, 小松 周平, 村松 智輝, 嶋田 裕, 河野 辰幸, 稲澤 譲治. 食道扁平上皮癌で高頻度に発現消失する新規癌抑制遺伝子候補protocad-herin 17(Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous-cell carcinoma (ESCC)) 日本癌学会総会記事. 2010.08; 69回 221. ( ichushi )

  72. Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S, Muramatsu T, Shimada Y, Kawano T, Inazawa J. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis. 2010.06; 31 (6): 1027-36. ( PubMed, DOI )

  73. 春木 茂男, 井本 逸勢, 小松 周平, 村松 智輝, 松井 毅, 小崎 健一, 河内 洋, 嶋田 裕, 河野 辰幸, 稲澤 譲治. 食道扁平上皮癌において高頻度に発現抑制される癌関連抑制遺伝子DESC1の同定(Identification of a potential tumor suppressor frequently silenced in esophageal squamous-cell carcinoma (ESCC)) 日本癌学会総会記事. 2009.08; 68回 134. ( ichushi )

  74. 村松 智輝, 井本 逸勢, 松井 毅, 小崎 健一, 津田 均, 嶋田 裕, 稲澤 譲治. 食道扁平上皮癌におけるYAP1とそのisoformの癌遺伝子としての機能(Functional significance of potential oncogene YAP1 and its isoforms in esophageal squamouse cell carcinoma (ESCC)) 日本癌学会総会記事. 2009.08; 68回 383. ( ichushi )

  75. Komatsu S, Imoto I, Tsuda H, Kozaki KI, Muramatsu T, Shimada Y, Aiko S, Yoshizumi Y, Ichikawa D, Otsuji E, Inazawa J. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis. 2009.07; 30 (7): 1139-46. ( PubMed, DOI )

  76. 村松 智輝, 井本 逸勢, 津田 均, 嶋田 裕, 小崎 健一, 稲澤 譲治. 食道癌発生におけるYes-associated protein 1(YAP1)増幅の意義(Significance of Yes-associated protein 1 (YAP1) amplification in esophageal carcinogenesis) 日本癌学会総会記事. 2008.09; 67回 142. ( ichushi )

  77. Goto Y, Hayashi R, Muramatsu T, Ogawa H, Eguchi I, Oshida Y, Ohtani K, Yoshida K. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. Biochimica et biophysica acta. 2006.01; 1759 (1-2): 60-8. ( PubMed, DOI )

▼display all